Genetic Factors in COPD Risk and Lung Health Protection

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on Lung & Respiratory Health. Browse all Lung & Respiratory Health education

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition in which airflow becomes limited by damaged airways and air sacs. Smoking is the dominant cause, but it is not the whole story: only a minority of smokers develop severe COPD, and some people who never smoked heavily still do. That gap points to genetics, which shapes how vulnerable a person's lungs are to injury and how well they defend and repair themselves.

What COPD is and how it develops

COPD is an umbrella term covering chronic bronchitis (inflamed, mucus-producing airways) and emphysema (destruction of the alveoli where gas exchange happens). The result is airflow that cannot fully reverse, leading to breathlessness that worsens over years. The core mechanism is an imbalance between injury — from inhaled smoke, pollution, or dust — and the lung's protective and repair systems. Genetics tips that balance by influencing both sides.

SERPINA1: the clearest genetic driver

The strongest single-gene contributor to COPD is SERPINA1, which encodes alpha-1 antitrypsin (AAT). AAT is a protective protein that shields lung tissue from an enzyme called neutrophil elastase, which would otherwise digest the elastic walls of the air sacs. Certain SERPINA1 variants — most notably the Z allele (the PiZZ genotype) — sharply lower AAT levels, leaving the lungs exposed. Alpha-1 antitrypsin deficiency is a recognized inherited cause of early-onset emphysema, and it can cause significant lung damage even in people who never smoked. It is underdiagnosed, which is why family and personal history of early COPD warrants attention.

Other genes that tune COPD susceptibility

Beyond SERPINA1, genome-wide studies have identified common variants with smaller effects. HHIP (hedgehog-interacting protein) influences lung development and function and is one of the most replicated COPD-associated loci. Variants in the CHRNA3/CHRNA5 nicotinic-receptor cluster affect smoking behavior and appear to influence lung risk partly through that route. Genes in antioxidant defense, such as GSTM1, shape how well the lung neutralizes the oxidative stress in smoke and pollution. Each adds a small amount to overall susceptibility.

How pathway insight fits your biology

These genes belong to broader lung-defense, protease-balance, and antioxidant pathways. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including named variants relevant to protective and repair pathways that shape your baseline respiratory biology. This is educational context, not a COPD diagnosis or a substitute for spirometry and clinical evaluation. If you have symptoms or a family history of early lung disease, that belongs in a conversation with a provider. Genetics is a guide, not a guarantee.

Protecting lung health, whatever your genetics

The single most powerful protective step is avoiding tobacco smoke — not starting, or stopping if you do smoke — because it removes the main source of the injury that genetic vulnerability amplifies. Reducing exposure to air pollution, occupational dusts, and secondhand smoke matters too, especially for people with a known SERPINA1 variant or family history. Staying active supports lung and cardiovascular fitness, and vaccination against respiratory infections reduces exacerbations. For those with alpha-1 antitrypsin deficiency, specialized medical care exists; that pathway starts with a provider, not self-management.

Frequently Asked Questions

Is COPD genetic or caused by smoking?

Both. Smoking is the leading cause, but genetics determines how vulnerable a person's lungs are to that damage. Alpha-1 antitrypsin deficiency, driven by SERPINA1 variants, can cause COPD even without heavy smoking. For most people, inherited susceptibility and inhaled exposures combine to determine overall risk.

What is the main gene involved in COPD?

SERPINA1 is the clearest single-gene driver. It encodes alpha-1 antitrypsin, a protein that protects lung tissue from enzymatic damage. Low-function variants like the Z allele cause alpha-1 antitrypsin deficiency, a recognized inherited cause of early emphysema. Common variants in HHIP, CHRNA3/5, and GSTM1 add smaller effects.

Can a genetic test diagnose COPD?

No. COPD is diagnosed clinically, primarily with spirometry that measures airflow, alongside symptoms and history. The Precision Peptide Genetic Test does not diagnose COPD; it offers pathway-level context about respiratory-defense biology. Any concern about lung disease should be evaluated by a qualified healthcare provider.

If I have a COPD-linked variant, will I definitely develop it?

Not necessarily. Even with a significant SERPINA1 variant, outcomes vary widely and are strongly influenced by smoke and pollutant exposure. Avoiding tobacco and reducing airborne irritants dramatically lowers risk. Knowing your genetic predisposition simply makes those protective choices more urgent and specific.

Curious how your own genetics shape this pathway? Take the Precision Peptide Genetic Test to see what your DNA reveals about your biology — then bring those insights to a conversation with your healthcare provider.

This article is part of the PlexusDx Education Hub. Browse all Lung & Respiratory Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.